×

Get the Prostate Cancer Patient Guide, available as a free emailed pdf.

Go here to learn more or to get a mailed copy.

The Prostate Cancer Foundation Announces Recipients of the 2018 PCF Young Investigator Awards
Total of $6 Million granted to 29 promising young scientists to support innovative research to defeat prostate cancer

LOS ANGELES, Calif., August 28, 2018 – The Prostate Cancer Foundation (PCF) announced today that it has granted a total of $6 million to 29 promising early career scientists dedicated to advancing critical research in developing better early detection methods, improving life-saving treatments and finding a cure for prostate cancer. Sponsored by the PCF, the Young Investigator Awards program provides both financial support and a comprehensive career development program to early career scientists with unique approaches and groundbreaking ideas to drive the critical research needed to defeat prostate cancer, a disease that nearly 14 million men worldwide are currently battling.

“We are honored to invest in new cutting-edge ideas for prostate cancer research.  This year’s recipients show great potential for unlocking new discoveries and achieving unprecedented strides toward research leading the way to help countless men affected by the disease,” said Jonathan Simons, MD, PCF’s President and CEO.

As a nonprofit organization committed to globally accelerating the development of new breakthroughs in prostate cancer, the PCF has invested more than $53 million to support 255 young investigators since 2007. The 2018 Young Investigator Awards recipients were selected from a pool of 103 applications from 55 institutions in 11 countries.

Recipients of the PCF Young Investigator Award must demonstrate significant promise for having a long-term and impactful career in the prostate cancer research field. Awardees must be within six years of completing professional scientific training programs and be under the guidance of at least one mentor.  Eleven of the 2018 PCF Young Investigator Awardees are conducting research to improve prostate cancer outcomes in U.S. Veterans.   Additional research focus areas include: novel precision medicine; new treatments and treatment strategies; immunotherapy; studying inherited genetic alterations for those at increased risk; and prostate cancer disparities particularly among African-American men.

 

The 2018 Young Investigator Awards recipients are:

NameInstitutionDonor(s)
Saud AlDubayan, MDHarvard: Dana-Farber Cancer InstitutePaz Littman and Morris Kahn
Mohammad Asim, PhDUniversity of Surrey, United KingdomClovis Oncology, Inc.
Hala Borno, MDUniversity of California, San FranciscoLenny Sands
Frank Cackowski, MD, PhDUniversity of MichiganJay Jordan
Megan Caram, MDUniversity of MichiganTony D. Minella
Kellie Cotter, PhDUniversity of Bern, SwitzerlandTodd Boehly
Anis Hamid, MBBSHarvard: Dana-Farber Cancer InstituteJeremy Coller
Jennifer Jones, MD, PhDNational Cancer InstituteNational Cancer Institute
Salma Kaochar, PhDBaylor College of MedicineJohn and Daria Barry Foundation
Sheng-Yu Ku, PhDWeill Cornell MedicineMichael and Lori Milken Family Foundation
Hui Li, PhDUniversity of California, San FranciscoJohn and Daria Barry Foundation
Brandon Mahal, MDHarvard: Dana-Farber Cancer InstituteAmerican Society for Radiation Oncology
Danil Makarov, MDNew York UniversityThomas H. Lee
Megan McNamara, MDDuke UniversityThomas Finke
Kent Mouw, MD, PhDHarvard: Dana-Farber Cancer InstituteRebecca and Nathan Milikowsky
Vivek Narayan, MDUniversity of Pennsylvania, Abramson Cancer CenterJames Maguire
David Oh, MD, PhDUniversity of California, San FranciscoJohn and Daria Barry Foundation
Eileen Parkes, MD, PhDQueen’s University Belfast, Northern IrelandFoundation 14
Raquel Perez-Lopez, MD, PhDVall d’Hebron Institute of Oncology, SpainGina Rinehart
Sethuramasundaram Pitchiaya, PhDUniversity of MichiganKeith Frankel, Michael DeAddio, and Thomas H. Lee
Nicholas Reder, MD, MPHUniversity of WashingtonSeth Bernstein
Zachery Reichert, MD, PhDUniversity of MichiganIgor Tulchinsky
Veronica Rodriguez-Bravo, PhDThomas Jefferson University, Sidney Kimmel Cancer CenterClay Hamlin in honor of H. Ward Hamlin Jr.
Joshua Russo, MD, PhDHarvard: Beth Israel Deaconess Medical CenterMichael and Lori Milken Family Foundation
Adam Sharp, MD, PhDInstitute of Cancer Research, London, United KingdomLarry Ruvo
Min Yuen Teo, MDMemorial Sloan Kettering Cancer CenterMichael and Lori Milken Family Foundation in Honor of Selma Rabin
Vasanthi Viswanathan, PhDHarvard: Broad Institute of MIT & HarvardSeth Bernstein
Scott Wilkinson, PhDNational Cancer InstituteNational Cancer Institute
David Wise, MD, PhDNew York UniversityJohn and Daria Barry Foundation

 

For more information about the 2018 Young Investigator Awards recipients, visit pcf.org/c/young-investigator-award-class-of-2018/.

About the Prostate Cancer Foundation (PCF): PCF is the world’s leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $765 million and provided funding to more than 2,000 research programs at nearly 210 cancer centers and universities. The PCF global research enterprise now extends to 22 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer. For more information, visit www.pcf.org.

 

#   #   #

MEDIA CONTACT:

Colleen McKenna
Prostate Cancer Foundation
(310) 570-4722
cmckenna@pcf.org

 

Donald Wilson
(310) 428-4730
dwilson.dwpr@gmail.com